Department of Medicine, University of California and Veterans Medical Research Foundation, La Jolla, San Diego, CA 92161, USA.
BJU Int. 2010 Aug;106(4):572-7. doi: 10.1111/j.1464-410X.2009.09105.x. Epub 2009 Dec 11.
To evaluate, in a well-controlled study, the effect of surgically induced partial bladder outlet obstruction (PBOO) on male erectile function in a rat model.
PBOO was created in 17 adult male Sprague-Dawley rats by partial ligation of the proximal urethra. Sham-operated and PBOO rats were evaluated for urodynamic and erectile function at 4-8 weeks after surgery. Erectile responses to electrical field stimulation (EFS) to the major pelvic ganglion, and to erectogenic agents (1,1-diethyl-2-hydroxy-2-nitroso-hydrazine, DEA-NO, and Y-27632) were evaluated and the area under the curve (AUC, a product of the intracavernous pressure and duration) was used to denote the erectile response.
Experimental PBOO in rats significantly increased the mean (sem) bladder weight, to 256 (25) mg in PBOO rats vs 123 (24) mg in sham controls, and the voiding frequency to 1.01 (0.1) voids/min vs 0.72 (0.14) voids/min in sham controls (P < 0.05). There was no significant difference between the erectile response to EFS, with a mean AUC in sham control rats at 1.5, 3.0 and 4.5 V of 2603 (372), 3200 (332) and 3357 (166), respectively, vs 2273 (183), 3794 (211) and 4177 (306) in PBOO rats (P > 0.05); or to the erectogenic agents, the AUC for DEA-NO being 9000 (975) in PBOO rats vs 13 201 (2756) in sham controls, and the AUC for Y-27 632 being 44 915 (2462) and 45 907 (7408), respectively (P > 0.05). There was greater immunoreactivity to RhoA in bladder and penile tissues of PBOO than control rats.
PBOO does not affect erectile function in rats. Additional mechanisms or pathways might be involved in lower urinary tract symptom-related erectile dysfunction in humans.
在一项精心控制的研究中,评估手术诱导的部分膀胱出口梗阻(PBOO)对雄性大鼠勃起功能的影响。
通过部分结扎近端尿道,在 17 只成年雄性 Sprague-Dawley 大鼠中建立 PBOO。术后 4-8 周,对假手术和 PBOO 大鼠进行尿动力学和勃起功能评估。用电场刺激(EFS)对主要盆神经丛的勃起反应,以及对勃起药物(1,1-二乙基-2-羟基-2-亚硝基肼,DEA-NO 和 Y-27632)的勃起反应进行评估,并使用曲线下面积(AUC,即 cavernous 压和持续时间的乘积)表示勃起反应。
在大鼠中,实验性 PBOO 显著增加了膀胱重量的平均值(sem),PBOO 大鼠为 256(25)mg,而假对照大鼠为 123(24)mg,排空频率为 1.01(0.1)次/分钟对 sham 对照组的 0.72(0.14)次/分钟(P < 0.05)。EFS 引起的勃起反应没有差异,假对照大鼠在 3.0 和 4.5 V 时 AUC 分别为 1.5、3.0 和 4.5 V,分别为 2603(372)、3200(332)和 3357(166),而 PBOO 大鼠的 AUC 分别为 2273(183)、3794(211)和 4177(306)(P > 0.05);或者对勃起药物,DEA-NO 的 AUC 为 PBOO 大鼠的 9000(975),而 sham 对照组的 AUC 为 13201(2756),Y-27632 的 AUC 分别为 44915(2462)和 45907(7408)(P > 0.05)。与假对照大鼠相比,PBOO 大鼠膀胱和阴茎组织中 RhoA 的免疫反应性更强。
PBOO 不会影响大鼠的勃起功能。在人类与下尿路症状相关的勃起功能障碍中,可能涉及其他机制或途径。